MedTrace Logo

Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome

NCT01774838 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2015-06-11

No results posted yet for this study

Summary

To test the vasoactive and anti-inflammatory effects of prasugrel in patients with acute coronary syndrome endothelial function -as a surrogate parameter of NO bioavailability- and different markers of inflammation, oxidative stress and platelet activation will be assessed in patients with unstable angina.

Conditions

  • Acute Coronary Syndrome
  • Unstable Angina

Interventions

DRUG

Prasugrel

3 months treatment

DRUG

Clopidogrel

3 months treatment

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Tanja Rudolph, MD · University Hospital of Cologne

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01774838 on ClinicalTrials.gov